Agoracom: Small Cap Investment - Mosaic ImmunoEngineering Inc. - Re: Prior at should be disclosed at the "Discovery Meeting"

Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Reply New Message

Back To Forum List View

Prior at should be disclosed at the "Discovery Meeting"

Albie

Nov 06, 2006 12:08PM

moxa1

Rank: Treasurer [?]

Points: 6576 [?]

Votes: 82 Score: 2.7 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Prior at should be disclosed at the "Discovery Meeting"

in response to

Prior at should be disclosed at the "Discovery Meeting"

Albie

posted on Nov 07, 2006 03:58AM

I believe ARM has until Dec.15th to disclose their prior art claims.

Reply New Message

Back To Forum List View

Please to post a reply